Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to -$0.3.

  • Caribou Biosciences' EPS (Basic) rose 2105.26% to -$0.3 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7, marking a year-over-year decrease of 240.96%. This contributed to the annual value of -$1.65 for FY2024, which is 1962.97% down from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' EPS (Basic) is -$0.3, which was up 2105.26% from -$0.58 recorded in Q2 2025.
  • Caribou Biosciences' 5-year EPS (Basic) high stood at -$0.12 for Q3 2023, and its period low was -$1.39 during Q2 2021.
  • Over the past 5 years, Caribou Biosciences' median EPS (Basic) value was -$0.44 (recorded in 2022), while the average stood at -$0.52.
  • As far as peak fluctuations go, Caribou Biosciences' EPS (Basic) tumbled by 53390.62% in 2021, and later surged by 7697.84% in 2022.
  • Over the past 5 years, Caribou Biosciences' EPS (Basic) (Quarter) stood at -$0.58 in 2021, then grew by 22.89% to -$0.45 in 2022, then rose by 11.11% to -$0.4 in 2023, then dropped by 7.61% to -$0.43 in 2024, then surged by 30.3% to -$0.3 in 2025.
  • Its EPS (Basic) was -$0.3 in Q3 2025, compared to -$0.58 in Q2 2025 and -$0.43 in Q1 2025.